http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101312422-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
filingDate 2005-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101312422-B1
titleOfInvention Anti-radical
abstract (1)n n n Compound of (1);n n n Formula (2)n n n The compound of (2); Andn n n Formula (3) Selected hindered nitroxy, hydroxylamine and hydroxylamine salt compounds, such as the compound of (3), exhibit marked anti-inflammatory action:n n n In the above formulas (1), (2) and (3),n n n G 1 is hydrogen; C 1 -C 22 alkyl; C 1 -C 22 alkylthio; C 2 -C 22 alkylthioalkyl; C 5 -C 7 cycloalkyl; Phenyl; C 7 -C 9 phenylalkyl; Or SO 3 M; G 2 is C 1 -C 22 alkyl; C 5 -C 7 cycloalkyl; Phenyl; Or C 7 -C 9 phenylalkyl; E is oxyl or hydroxyl; V is -O-; Or -NH-; ; a is 0 or 1 or 2; b, c and d and g are each independently 0 or 1; e is an integer from 1 to 4; f, m, n and p are each independently an integer from 1 to 3; q is 0 or an integer from 1 to 3; Q, T and G 3 are as defined in claim 1; G 4 and G 5 are independently of each other hydrogen; Or C 1 -C 22 alkyl.n n n Anti-inflammatory action, steric hindrance nitroxyl, hydroxylamine, hydroxylamine, pharmaceutical composition, allergy, skin damage
priorityDate 2004-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0025731-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467534987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415428504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149773381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467129590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466553255

Total number of triples: 21.